Phase 2 Trial of Lapatinib With Cisplatin and Radiation for Head and Neck Cancer

Share this content:
Researchers are evaluating whether lapatinib with cisplatin and radiation is safe and efficacious for patients with HPV-negative head and neck cancer.
Researchers are evaluating whether lapatinib with cisplatin and radiation is safe and efficacious for patients with HPV-negative head and neck cancer.

Title: TRYHARD: A Phase II, Randomized, Double Blind, Placebo-Controlled Study of Lapatinib (Tykerb®) for Non-HPV Locally Advanced Head and Neck Cancer With Concurrent Chemoradiation1

Principal Investigators: Stuart Wong, MD, Medical College of Wisconsin

Description: For this phase 2, randomized trial, researchers are evaluating whether lapatinib with cisplatin and radiation is safe and efficacious for patients with HPV-negative head and neck cancer.

The trial has 2 arms. In both arms patients will receive intensity-modulated radiation therapy and cisplatin. In the experimental arm only patients will also receive lapatinib.

The primary outcome is progression-free survival. Secondary outcomes include distant metastasis, adverse events, compliance, and overall survival.

The estimated study enrolment is 142 patients.

Lapatinib is an orally administered dual–tyrosine kinase inhibitor.

For more study information, including inclusion and exclusion criteria, study locations, and contact information, visit https://clinicaltrials.gov/ct2/show/NCT01711658.

Status: This study is open and recruiting patients as of July 12, 2017.

This study is sponsored by the Radiation Therapy Oncology Group in collaboration with GlaxoSmithKline, NRG Oncology, and Novartis.

Reference

  1. Clinicaltrials.gov. TRYHARD: Radiation therapy plus cisplatin with or without lapatinib in treating patients with head and neck cancer. (TRYHARD). NCT01711658. https://clinicaltrials.gov/ct2/show/NCT01711658. Accessed July 12, 2017.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters